Drug Extends Survival in Patients with Drug-Resistant Prostate Cancer

A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression of prostate cancer.

Data Show 15 Percent Drop in Prostate Cancer Deaths

WASHINGTON, Feb. 7, 2012 /PRNewswire-USNewswire/ -- While more men are being diagnosed with the prostate cancer, fewer are dying from the disease. Data from the North American Association of Central Cancer Registries and the National Center for Health Statistics, Centers for Disease Control and Prevention show that in 2012, incidence rates of prostate cancer will increase slightly, while death ...